Definitive Healthcare Corp.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
DH$1.19+6.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets (Unaudited)
CONDENSED CONSOLID ATED BALANCE SHEETS
(in thousands, except number of shares and par value)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $157,648 | $163,627 |
| Short-term investments | 20,447 | 17,262 |
| Accounts receivable, net | 38,941 | 51,978 |
| Prepaid expenses and other assets | 16,279 | 11,972 |
| Deferred contract costs | 12,441 | 12,766 |
| Total current assets | 245,756 | 257,605 |
| Property and equipment, net | 13,798 | 12,680 |
| Operating lease right-of-use assets, net | 4,880 | 5,394 |
| Other assets | 2,578 | 2,277 |
| Deferred contract costs | 12,293 | 12,840 |
| Intangible assets, net | 235,433 | 247,477 |
| Goodwill | — | 197,219 |
| Total assets | $514,738 | $735,492 |
| Liabilities and Equity | ||
| Current liabilities: | ||
| Accounts payable | $6,024 | $3,596 |
| Accrued expenses and other liabilities | 23,916 | 44,773 |
| Deferred revenue | 99,055 | 96,989 |
| Term loan | 8,750 | 8,750 |
| Operating lease liabilities | 2,657 | 2,679 |
| Total current liabilities | 140,402 | 156,787 |
| Long term liabilities: | ||
| Deferred revenue | 116 | 2,383 |
| Term loan | 153,985 | 156,085 |
| Operating lease liabilities | 4,449 | 5,152 |
| Tax Receivable Agreement liability | 12,378 | 19,212 |
| Deferred tax liabilities | 11,087 | 14,634 |
| Other liabilities | 1,622 | 2,247 |
| Total liabilities | 324,039 | 356,500 |
| Equity: | ||
| Class A common stock, par value $0.001, 600,000,000 shares authorized, 105,263,448 and 104,020,957 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 105 | 104 |
| Class B common stock, par value $0.00001, 65,000,000 shares authorized, 38,225,333 and 38,339,076 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Additional paid-in capital | 1,065,811 | 1,061,965 |
| Accumulated other comprehensive deficit | (1,555) | (1,450) |
| Accumulated deficit | (918,127) | (779,506) |
| Noncontrolling interests | 44,465 | 97,879 |
| Total equity | 190,699 | 378,992 |
| Total liabilities and equity | $514,738 | $735,492 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.